Compare Quest Diagnostics Inc (DGX) vs Enovix Corporation (ENVX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Quest Diagnostics Inc vs Enovix Corporation — how do they compare? Quest Diagnostics Inc trades at $237.5 (market cap $26.21B), while Enovix Corporation trades at $4.85 (market cap $1.06B). The key difference: Quest Diagnostics Inc is far larger — about 24.7× Enovix Corporation's market cap, and Quest Diagnostics Inc pays a 1.45% dividend while Enovix Corporation pays none. Which is the better fit depends on your goals.
| DGX | ENVX | |
|---|---|---|
Market Cap | $26.21B | $1.06B |
Sector | Health | Technology |
52-Week High | $238.50 | $13.19 |
52-Week Low | $173.49 | $3.68 |
Enterprise Value | $31.97B | $1.07B |
Dividend Yield | 1.45% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →About Enovix Corporation
Enovix designs and manufactures advanced silicon-anode lithium-ion batteries. Its technology aims to provide high energy density and improved performance for mobile devices and consumer electronics.
Read more on ENVX →
